ERIC PIERMONT/AFP/Getty Images
Sanofi Genzyme’s manufacturing facility at Allston Landing in Boston is laying off 130 employees this week to reduce costs and “simplify our operations,” the company said Wednesday.
“We must be flexible in our operations to remain competitive in a dynamic and challenging healthcare environment,” Ashleigh Koss, spokeswoman for the French parent company, Sanofi SA, said in a statement.
Koss would not say how many workers remain at the facility but said Sanofi has about 5,000 employees in Massachusetts — in Allston, Cambridge, Framingham, Northborough, Waltham, and Westborough. They work in research and development, biomanufacturing, and commercial operations.
The Allston Landing plant will remain a biomanufacturing site, she said.
In 2011, Sanofi bought Cambridge-based Genzyme Corp., which specialized in developing medicines for rare diseases, for more than $20 billion. Genzyme, which was renamed Sanofi Genzyme, essentially became the rare-disease unit of Sanofi, which employs about 100,000 people worldwide.
Last month, Sanofi made a major acquisition, paying $11.6 billion to buy the hemophilia drug maker Bioverativ Inc., of Waltham. Biogen Inc., the largest Massachusetts-based drug maker, spun off Bioverativ as a separate company in 2017.
Nicole Slotterbeck wasn’t just annoyed by the “mystery” packages that kept arriving from Amazon. She was frightened. First was the bra — in her size. Then came even more intimate merchandise.Continue reading »
Two recent Globe stories about Amazon customers receiving packages they never ordered generated tremendous response from readers who have experienced the same thing.Continue reading »
Many of the employees have worked for Partners for several years, or even decades.Continue reading »
Airbnb will have inspectors rate thousands of listed properties in an effort to reassure travelers they’re booking nice places.Continue reading »
You no longer have to wait a week for a card to arrive in the mail before you can hop in one of the company’s vehicles.Continue reading »
The Boston-based furniture retailer on Thursday posted a wider-than-expected quarterly loss, and its stock fell the most since the company went public in 2014.Continue reading »
Nine stories you may have missed Tuesday from the world of business.Continue reading »
Even though the drug isn’t fully legal in Mass., companies are lining up for a potential expansion of the market.Continue reading »
New research suggests prejudices may form at a much earlier age, but it also offers hope that biases can be unlearned.Continue reading »